Maryland State Retirement & Pension System Trims Holdings in Teleflex Incorporated $TFX

Maryland State Retirement & Pension System reduced its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 43.8% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 8,523 shares of the medical technology company’s stock after selling 6,633 shares during the period. Maryland State Retirement & Pension System’s holdings in Teleflex were worth $1,043,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the business. Russell Investments Group Ltd. increased its stake in Teleflex by 23.6% during the 2nd quarter. Russell Investments Group Ltd. now owns 83,388 shares of the medical technology company’s stock valued at $9,870,000 after purchasing an additional 15,935 shares in the last quarter. Speece Thorson Capital Group Inc. grew its holdings in shares of Teleflex by 2.4% during the second quarter. Speece Thorson Capital Group Inc. now owns 89,843 shares of the medical technology company’s stock valued at $10,634,000 after buying an additional 2,096 shares during the last quarter. Creative Planning increased its position in shares of Teleflex by 76.5% during the second quarter. Creative Planning now owns 10,338 shares of the medical technology company’s stock valued at $1,224,000 after acquiring an additional 4,480 shares in the last quarter. CWM LLC raised its holdings in Teleflex by 160.8% in the 2nd quarter. CWM LLC now owns 11,904 shares of the medical technology company’s stock worth $1,409,000 after acquiring an additional 7,340 shares during the last quarter. Finally, Teacher Retirement System of Texas raised its holdings in Teleflex by 31.5% in the 2nd quarter. Teacher Retirement System of Texas now owns 11,819 shares of the medical technology company’s stock worth $1,399,000 after acquiring an additional 2,831 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Teleflex Trading Down 2.7%

Shares of NYSE:TFX opened at $100.26 on Wednesday. The stock’s 50-day simple moving average is $116.59 and its two-hundred day simple moving average is $120.34. The stock has a market capitalization of $4.43 billion, a price-to-earnings ratio of -13.64, a PEG ratio of 1.34 and a beta of 0.93. Teleflex Incorporated has a 52-week low of $100.18 and a 52-week high of $185.94. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, November 6th. The medical technology company reported $3.67 EPS for the quarter, beating the consensus estimate of $3.38 by $0.29. Teleflex had a negative net margin of 10.28% and a positive return on equity of 15.64%. The firm had revenue of $892.90 million during the quarter, compared to analyst estimates of $892.79 million. During the same quarter in the prior year, the firm earned $3.49 EPS. The business’s revenue for the quarter was up 19.4% compared to the same quarter last year. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. Analysts expect that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, December 15th. Shareholders of record on Friday, November 14th were given a $0.34 dividend. The ex-dividend date was Friday, November 14th. This represents a $1.36 annualized dividend and a yield of 1.4%. Teleflex’s dividend payout ratio (DPR) is presently -18.50%.

Analyst Upgrades and Downgrades

A number of research firms have commented on TFX. Royal Bank Of Canada reissued a “sector perform” rating and issued a $135.00 target price on shares of Teleflex in a report on Wednesday, December 17th. Zacks Research cut Teleflex from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 30th. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a report on Tuesday, December 9th. Wells Fargo & Company upped their target price on shares of Teleflex from $114.00 to $139.00 and gave the company an “equal weight” rating in a research note on Wednesday, December 10th. Finally, Wall Street Zen downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. One research analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Reduce” and a consensus price target of $142.43.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.